Stemedica Announces International Educational Collaboration With Smart Living
San Diego, CA (PRWEB) March 26, 2014 -- Stemedica Cell Technologies, Inc., a specialty biopharmaceutical company that manufactures best-in-class allogeneic adult stem cells and Smart Living, a subsidiary of Smart Global, a $2 billion (USD) globally diversified conglomerate, are pleased to announce an international educational collaboration.
Smart Living currently organizes dynamic “One World” educational conferences designed to introduce breakthrough technologies and educational programs focused on health care and regenerative medicine to countries throughout the world. High profile leaders in medicine, science, business, education, government and community organizers are brought together at these international forums to participate in presentations, discussions and educational programs.
Stemedica, a global leader in regenerative medicine focused on stem cell research and clinical trials, has been selected to introduce breakthrough technologies in the dynamic field of stem cells and their role in translational medicine.
In addition to the educational outreach, Smart Living is making significant advances in health care with its Smart Health City model. This model, anticipated to go global, was developed to be an all-inclusive health care destination offering services including multispecialty hospitals, medical office buildings, medical rehabilitation centers, international patient care centers, medical education and training, clinical research, on campus staff residence, research and technology center. The first of these Health Cities is on 15 acres located in Saket in the heart of Delhi, India.
Swati Saxena, MD, Programme Director at Smart Living said, “What makes Smart Living a unique concept is that it provides integrated and converged facilities where strong scientific evidence is paired with health and wellness initiatives in a step-by-step methodic fashion guided by medical experts.”
Dr. Bhupendra Kumar (“BK”) Modi, PhD, Chairman Smart Global and Founder of Smart Living said, “We are delighted to make an investment into, and to collaborate with, Stemedica. Our objective is to implement sophisticated technologies, advance new and improved innovations and encourage research for the betterment of the health of society. As Smart Living continues its worldwide educational efforts to promote health and wellbeing, Stemedica’s leadership in the regenerative medicine movement is an ideal fit for our efforts.”
Roger A. Howe, PhD, Stemedica’s Executive Chairman said about the collaboration, “This is an excellent opportunity to contribute to Dr. Modi’s “One World” educational forums. As an active participant in these forums, we will be able to promote healthier lifestyles in communities around the world. Stemedica, together with Smart Living, will emphasize the importance of new innovations that lead to medical breakthroughs in regenerative medicine, including Stemedica’s stem cell technologies.”
As part of the collaboration, Mr. Ozi Amanat, Smart Global Chief Investment Officer will become a business advisor to Stemedica. In accepting the appointment, Mr. Amanat said, “I’m honored to be working with Stemedica and its leadership. Stemedica is poised to bring the power and potential of regenerative medicine to the world. Stemedica’s leadership in this field is exciting and I look forward to supporting their continued growth as well as creating maximum value to both organizations.”
Smart Living has made an undisclosed investment in Stemedica.
About Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class allogeneic adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government licensed manufacturer of clinical grade stem cells and is approved by the FDA for clinical trials in ischemic stroke, cutaneous photoaging and acute myocardial infarction. Stemedica is currently developing regulatory pathways for a number of other medical indications using adult allogeneic stem cells. The company is headquartered in San Diego, California.
For more information regarding Stemedica Cell Technologies, Inc., please contact Dave McGuigan, Vice President of Marketing and Business Development: dmcguigan (at) stemedica (dot) com
About Smart Global
Smart Global formerly Spice Global, is a $2 billion (USD) diversified conglomerate that encompasses a variety of businesses that harness speed, creativity and efficiency to invest, develop and market products that are defining how we live today. It currently serves over 25 million customers worldwide across various sectors – telecom, finance, entertainment technology and healthcare. Established by renowned global entrepreneur and futurepreneur, Dr. Bhupendra Kumar Modi, Spice Global has expanded its footprint across Los Angeles, San Francisco, New York, London, New Delhi, Bombay, Dubai, Kuala Lumpur in addition to China and Africa.
For further information regarding Smart Global, please contact Arem Mukim, Manager Brand & Communications: Arem.mukim (at) spiceglobal (dot) com
Dave McGuigan, Stemedica Cell Technologies Inc, (858) 658-0910, [email protected]
Share this article